Dendritic Cell-Based Immunotherapy for Solid Tumors()()

As a treatment for solid tumors, dendritic cell (DC)-based immunotherapy has not been as effective as expected. Here, we review the reasons underlying the limitations of DC-based immunotherapy for solid tumors and ask what can be done to improve immune cell-based cancer therapies. Several reports sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Nam-Chul, Lee, Jun-Ho, Chung, Kwang-Hoe, Kwak, Yi Sub, Lim, Dae-Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154348/
https://www.ncbi.nlm.nih.gov/pubmed/29627706
http://dx.doi.org/10.1016/j.tranon.2018.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154348/
https://www.ncbi.nlm.nih.gov/pubmed/29627706
http://dx.doi.org/10.1016/j.tranon.2018.03.007

Ejemplares similares